OSIR

Osiris Therapeutics, Inc. Press Releases

$13.5
*  
0.01
0.07%
Get OSIR Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Osiris Therapeutics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum
11/17/2014 8:00:00 AM - Business Wire


Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable
11/7/2014 8:00:00 AM - Business Wire
▼-2.46 % Price Change since this news event. The Volume Ratio is 2.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform®
10/17/2014 8:00:00 AM - Business Wire
▲2.35 % Price Change since this news event. The Volume Ratio is 1.49.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds
10/16/2014 8:00:00 AM - Business Wire
▲6.55 % Price Change since this news event. The Volume Ratio is 2.01.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call
10/13/2014 8:00:00 AM - Business Wire
▲12.03 % Price Change since this news event. The Volume Ratio is 0.79.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa
9/25/2014 8:00:00 AM - Business Wire


Grafix® Featured in Plenary Session Oral Presentation at the Joint Annual Meeting of the Eastern and New England Vascular Societies
9/15/2014 4:15:00 PM - Business Wire


Grafix® Randomized Controlled Clinical Trial Recognized as High Quality DFU Trial in Recent Wounds Supplement
9/11/2014 9:00:00 AM - Business Wire